These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Antimicrobial resistance in community-acquired urinary tract infections in Paris in 2015. Chervet D; Lortholary O; Zahar JR; Dufougeray A; Pilmis B; Partouche H Med Mal Infect; 2018 May; 48(3):188-192. PubMed ID: 29054298 [TBL] [Abstract][Full Text] [Related]
25. Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study. Esteve-Palau E; Solande G; Sánchez F; Sorlí L; Montero M; Güerri R; Villar J; Grau S; Horcajada JP J Infect; 2015 Dec; 71(6):667-74. PubMed ID: 26380898 [TBL] [Abstract][Full Text] [Related]
26. Does urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli show same antibiotic resistance when it recurs? Ahn ST; Kim SW; Kim JW; Park HS; Moon DG; Oh MM J Infect Chemother; 2019 Jul; 25(7):498-502. PubMed ID: 30852104 [TBL] [Abstract][Full Text] [Related]
27. Increasing community prevalence of extended-spectrum beta-lactamase-producing Escherichia coli in urine is associated with increasing district-level antibiotic consumption. Nunes LHS; Ribeiro VST; Salviato RB; de Andrade AP; Suss PH; Vicenzi FJ; Hino AAF; Telles JP; Tuon FF FEMS Microbiol Lett; 2024 Jan; 371():. PubMed ID: 38821516 [TBL] [Abstract][Full Text] [Related]
28. The prevalence and predictors of extended spectrum B-lactamase urinary tract infections among emergency department patients: A retrospective chart review. Bou Chebl R; Assaf M; Kattouf N; Abou Arbid S; Haidar S; Geha M; Makki M; Tamim H; Abou Dagher G Am J Emerg Med; 2021 Nov; 49():304-309. PubMed ID: 34182275 [TBL] [Abstract][Full Text] [Related]
29. Worrisome high frequency of extended-spectrum beta-lactamase-producing Escherichia coli in community-acquired urinary tract infections: a case-control study. Castillo-Tokumori F; Irey-Salgado C; Málaga G Int J Infect Dis; 2017 Feb; 55():16-19. PubMed ID: 27979787 [TBL] [Abstract][Full Text] [Related]
30. Molecular characteristics and antibiotic resistance profiles of Escherichia coli strains isolated from urinary tract infections in children admitted to children's referral hospital of Qom, Iran. Pourakbari B; Mamishi S; Shokrollahi MR; Heydari H; Mahmoudi S; Banar M; Sadeghi RH; Movahedi Z Ann Ig; 2019; 31(3):252-262. PubMed ID: 31069370 [TBL] [Abstract][Full Text] [Related]
31. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities. Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907 [TBL] [Abstract][Full Text] [Related]
32. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common. Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462 [TBL] [Abstract][Full Text] [Related]
33. Prospective cohort study of risk factors for extended-spectrum ß-lactamase-producing Escherichia coli urinary tract infections in elderly patients admitted to hospital. Artero A; Esparcia A; Alberola J; Madrazo M; Nogueira JM; Eiros JM Int J Clin Pract; 2017 Sep; 71(9):. PubMed ID: 28873266 [TBL] [Abstract][Full Text] [Related]
35. Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients. Fatima S; Muhammad IN; Usman S; Jamil S; Khan MN; Khan SI Indian J Pharmacol; 2018; 50(2):69-74. PubMed ID: 30100654 [TBL] [Abstract][Full Text] [Related]
36. Epidemiological factors associated with ESBL- and non ESBL-producing E. coli causing urinary tract infection in general practice. Hertz FB; Schønning K; Rasmussen SC; Littauer P; Knudsen JD; Løbner-Olesen A; Frimodt-Møller N Infect Dis (Lond); 2016; 48(3):241-5. PubMed ID: 26523346 [TBL] [Abstract][Full Text] [Related]
37. Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology. Espinar MJ; Miranda IM; Costa-de-Oliveira S; Rocha R; Rodrigues AG; Pina-Vaz C PLoS One; 2015; 10(8):e0134737. PubMed ID: 26237422 [TBL] [Abstract][Full Text] [Related]
38. [Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase producing urinary isolates of Escherichia coli in outpatients]. Marković T; Jeinić L; Smitran A; Petković M Srp Arh Celok Lek; 2013; 141(11-12):775-9. PubMed ID: 24502096 [TBL] [Abstract][Full Text] [Related]
39. Community-onset extended-spectrum β-lactamase producing Escherichia coli in urinary tract infections in children from 2015 to 2016: Prevalence, risk factors, and resistances. Pérez Heras I; Sanchez-Gomez JC; Beneyto-Martin P; Ruano-de-Pablo L; Losada-Pinedo B Medicine (Baltimore); 2017 Dec; 96(50):e8571. PubMed ID: 29390257 [TBL] [Abstract][Full Text] [Related]
40. Prevalence of fluoroquinolone-resistant and broad-spectrum cephalosporin-resistant community-acquired urinary tract infections in Rio de Janeiro: Impact of Escherichia coli genotypes ST69 and ST131. de Souza da-Silva AP; de Sousa VS; de Araújo Longo LG; Caldera S; Baltazar ICL; Bonelli RR; Santoro-Lopes G; Riley LW; Moreira BM Infect Genet Evol; 2020 Nov; 85():104452. PubMed ID: 32634601 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]